The disorder has been designated as spasticty, childhood early onset with hyperglycinemia OMIM #616859 ‘S–SPAHGC, highlighting the dominant phenotypic feature in these patients namely spastic paraplegia. The gene discussed is GLRX5; the disease is Spastic paraplegia.